Analysts Rate IQVIA Holdings Inc. as a Moderate Buy

IQVIA Holdings Inc. (NYSE:IQV - Get Free Report) has recently received an average recommendation of "Moderate Buy" from the nineteen research firms currently analyzing the stock. This information comes from Marketbeat Ratings. Out of these analysts, four have given the stock a hold rating, while fourteen have rated it as a buy. Furthermore, one analyst has recommended a strong buy, indicating a favorable outlook on the company's performance.

The average target price for IQVIA stock among the brokers who have issued reports in the past year is set at $256.50. This figure suggests that analysts believe there is potential for the stock to increase over time.

Recently, several equity research analysts have commented on IQV shares. For instance, JPMorgan Chase & Co. adjusted their price target for IQVIA from $279.00 to $240.00 and rated it as "overweight" in a report dated November 5th. Redburn Atlantic initiated coverage on IQVIA on October 14th, assigning it a buy rating with a price target of $276.00. StockNews.com downgraded IQVIA from a buy rating to a hold rating in their report released on November 28th.

Additionally, Morgan Stanley revised their target price for IQVIA from $280.00 down to $265.00, while maintaining an "overweight" rating on November 4th. Evercore ISI also reduced their price target on IQVIA from $270.00 to $265.00, while rating the stock as "outperform" in an October 8th report.

Current Stock Performance

The shares of IQVIA opened at $202.63 on Friday. The company currently has a 50-day moving average of $215.18 and a 200-day moving average of $225.14. IQVIA’s quick ratio stands at 0.81, and its current ratio is also at 0.81. The debt-to-equity ratio for the company is recorded at 1.76. IQVIA enjoys a market capitalization of $36.78 billion, a price-to-earnings ratio of 26.59, and a price-to-earnings-growth ratio of 2.06, with a beta of 1.49. Over the past 52 weeks, the stock has had a low of $187.62 and a high of $261.73.

Institutional Investor Activity

Recent trades by institutional investors and hedge funds reveal a significant interest in IQVIA shares. Opal Wealth Advisors LLC acquired a new position in IQVIA during the second quarter for roughly $27,000. Similarly, Capital Performance Advisors LLP bought a new stake worth about $27,000 in the third quarter. Park Place Capital Corp entered a new position valued at approximately $28,000, while Itau Unibanco Holding S.A. purchased shares worth about $29,000 in the second quarter. Moreover, International Assets Investment Management LLC acquired a stake in IQVIA in the second quarter for around $32,000. Currently, institutional investors and hedge funds collectively own approximately 89.62% of IQV's stock.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. specializes in providing advanced analytics, technology solutions, and clinical research services to the life sciences sector across the Americas, Europe, Africa, and the Asia-Pacific region. The company operates through three primary segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA, Stock, Analysis